NEWS | BEAM Alliance

NEWS

NovaBiotics Awarded £1.8m in Small Business Research Innovation-Innovate UK grant funding to Advance its Antifungal Drug Candidate, Novamycin

NovaBiotics Awarded £1.8m in Small Business Research Innovation-Innovate UK grant funding to Advance its Antifungal Drug Candidate, Novamycin

Aberdeen, UK, 18th February 2019 – NovaBiotics Ltd (NovaBiotics) has secured £1.8 million in grant funding as part of a Department of Health and Social Care (DHSC) research competition aimed at tackling antimicrobial resistance in humans. The funding is to further develop Novamycin, NovaBiotics’ first-in-class antifungal compound with potential to combat life threatening and drug resistant blood stream and tissue fungal infections.

Full PR available here